Rent the Runway Inc vs Revolution Medicines Inc. Common Stock — how do they compare? Rent the Runway Inc trades at $1.77 (market cap $61.75M), while Revolution Medicines Inc. Common Stock trades at $189.76 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 653× Rent the Runway Inc's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, Rent the Runway Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Rent the Runway Inc for 56 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| RENT | RVMD | |
|---|---|---|
Market Cap | $61.75M | $40.32B |
Volume | 193,323 | 4,855,734 |
Sector | Consumer Cyclical | Health |
52-Week High | $9.39 | $221.15 |
52-Week Low | $1.55 | $47.50 |
Typical Hold Time | 56 Days | 0 Days |
Enterprise Value | $228.75M | $37.02B |
Signals from Pluang's Aura AI — not financial advice
Rent the Runway (RENT) trades at $1.77, up 5.36% today, with a bullish technical signal despite mixed indicators. The company reported Q2 2026 revenue growth of 20.8% year-over-year to $97.7 million, with improved gross margins, and appointed Paige Thomas as CEO in September 2026. However, it faces negative shareholder equity of -$182.5 million and a high debt-to-asset ratio of 139.62% as of 2025, though net losses have narrowed from -$212 million in 2022 to -$69.9 million in 2025.
The outlook is cautiously optimistic, with revenue growth and margin expansion offering potential upside, but significant financial leverage and ongoing legal investigations pose substantial risks. Analyst consensus is mixed, with 42% buy ratings, reflecting the balance between operational improvements and balance sheet concerns.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Rent the Runway Inc is an e-commerce platform that allows users to rent, subscribe, or buy designer apparel and accessories.
Read more on RENT →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →